Application no. and date | 12790891.1 (espacenet) (Federated) (European Patent Register), 20121121 | Patent/reg. no. and date | DK/EP 2782914, 20180801 | Publication date | 20141001 | Priority no. and date | EP 11190789, 20111125, EP 11192301, 20111207 | EP pub. no. and date |
EP 2782914 20141001 | Effective date | | Applicant/owner | Adverio Pharma GmbH, Kaiser-Wilhelm-Allee 1
51373 Leverkusen, DE | Applicant ref. no. | BBS BHC111050PCT-EP | Inventor | FEY, Peter, Am Eickhof 23
42111 Wuppertal, DE, BIERER, Donald, Horst 9
42781 Haan, DE, GRUNENBERG, Alfons, Bismarckstr. 87
42115 Wuppertal, DE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/506 (2006.01) , A61P 9/00 (2006.01) , C07D 471/04 (2006.01) | Title | FREMGANGSMÅDE TIL FREMSTILLING AF SUBSTITUEREDE 5-FLUOR-1H-PYRAZOLOPYRIDINER | Int. application no. | EP2012073276 | Int. publication no. | WO2013076168 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|